FindTrial
Sign In

The effect of stellate ganglion block on the recovery in patients with COVID-19

The effect of stellate ganglion block on the recovery in patients with COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068799
Enrollment
Unknown
Registered
2023-03-01
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

COVID-19 intervention group:Stellate ganglion block and conventional treatment
Control group:Conventional treatment

Sponsors

Fujian Provincial Hospital South Branch
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) COVID-19 patients; (2) Gender is not limited; (3) Age> 18 years old; (4) BMI < 35kg/m^2; (5) The patient or family members sign the informed consent form

Exclusion criteria

Exclusion criteria: (1) local anesthetic drug allergy (2) coagulation dysfunction (3) trauma and local infection in the area of nerve block; (4) changes in neck anatomy; (5) patients who were intubated and mechanically ventilated before the study; (6) known hypersensitivity to any drug used for anesthesia or any of its excipients; (7) Pregnant or lactating women (8) Uncontrolled hypotension or life-threatening comorbidities

Design outcomes

Primary

MeasureTime frame
C-reactive protein;IL-6;Blood routine;Myocardial enzyme;Heart rate variability index;—

Secondary

MeasureTime frame
Sleep quality;—

Countries

China

Contacts

Public ContactWu Xiaodan

Department of Anesthesiology, Fujian Provincial Hospital South Branch

wxiaodan@sina.com+86 13055291720

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026